Evidence map›Paper›PMID 40523654›Full record

ReviewObesity reviews : an official journal of the International Association for the Study of Obesity2025

Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview.

Cinzia Giordano, Marianna Puzzo, Rocco Malivindi, Debora Cristofaro, Luca Gelsomino, Daniela Bonofiglio, Carlo Capalbo, Sebastiano Andò, Ines Barone, Stefania Catalano

Abstract readReview
In one paragraph

Review in Obesity reviews : an official journal of the International Association for the Study of Obesity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cinzia GiordanoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.ORCID 0000-0003-4969-0607
Marianna PuzzoClinical Laboratory Unit, A.O. "Annunziata", Cosenza, Italy.
Rocco MalivindiDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Debora CristofaroDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Luca GelsominoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Daniela BonofiglioDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Carlo CapalboDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Sebastiano AndòDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.
Ines BaroneDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.ORCID 0000-0002-9769-1615
Stefania CatalanoDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Cosenza, Italy.

Funding

AIRC Investigator Grant (IG) 26246AIRC Investigator Grant (IG) 30782National Plan for NRRP Complementary Investments - AdvaNced Technologies for Human-centrEd Medicine (ANTHEM) PNC0000003POS CAL.HUB.RIA project funded by the Italian Minister of Health H53C22000800006POS RADIOAMICA project funded by the Italian Minister of Health H53C22000650006PRIN 2017 2017WNKSLRPRIN 2022, European Union's NextGenerationEU initiative under the Italian Ministry of University and Research 2022AA4FTJPRIN 2022, European Union's NextGenerationEU initiative under the Italian Ministry of University and Research M4C2-I1.1 202239N8PRPRIN 2022, European Union's NextGenerationEU initiative under the Italian Ministry of University and Research P2022YAKJY
6 · The paper itself

Abstract

The steadily increasing prevalence of obesity and its association with a growing number of malignancies, including breast cancer, has made this disease spectrum an urgent and critical public health priority, demanding immediate attention and comprehensive action. To date, a growing body of research has been dedicated to the study of obesity/breast cancer biological link, with the most well-documented mechanisms involving chronic inflammation, altered adipokine levels, dysregulated hormone signaling, and insulin/growth factor pathways. Despite significant progress, a substantial gap persists in our present comprehension of the association between adiposity and breast cancer biology in individuals with mutations in the BRCA1/2 genes, the most widely known high-penetrance genes involved in severe breast cancer risk. In this review, we first give an overview of the contribution of BRCA1/2 gene mutations in breast cancer development. Then, we discuss the emerging mechanistic evidence linking obesity with breast cancer, highlighting the impact of metabolic and hormonal factors in BRCA mutation carriers. Insights into the cross-talk between obesity and breast cancer development in BRCA mutation carriers may pave the way to improve proper personalized clinical management of BRCA1/2-associated breast cancer.

Indexed as

BRCA1 ProteinBreast NeoplasmsGenes, BRCA1Genes, BRCA2ObesityFemaleGenetic Predisposition to DiseaseHumansMutationBRCA1 ProteinBRCA1 protein, humanBRCA1BRCA2breast cancerobesity

Identifiers

PMID40523654
PMCPMC12620108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.